Pharmacological subgroup
J01D – ANDERE BETA-LACTAM-ANTIBIOTIKA
9Decisions
31Patient groups
Added benefit by patient group
- Deemed proven31
Subgroups
- J01DD Cephalosporine der 3. Generation 2 decisions
- J01DE Cephalosporine der 4. Generation 1 decision
- J01DH Carbapeneme 3 decisions
- J01DI Andere Cephalosporine und Peneme 3 decisions
Decisions, newest first
- 2026-08-06RecarbrioImipenem/Cilastatin/RelebactamDeemed proven: 3 of 3 patient groups
- 2025-05-15ZaviceftaCeftazidim/AvibactamDeemed proven: 4 of 4 patient groups
- 2025-04-17VaboremMeropenem/VaborbactamDeemed proven: 5 of 5 patient groups
- 2024-12-05ExblifepCefepim/EnmetazobactamDeemed proven: 3 of 3 patient groups
- 2023-02-02ZerbaxaCeftolozan/TazobactamDeemed proven: 3 of 3 patient groups
- 2022-11-03ZaviceftaCeftazidim/AvibactamDeemed proven: 5 of 5 patient groups
- 2022-11-03ZerbaxaCeftolozan/TazobactamDeemed proven: 4 of 4 patient groups
- 2022-11-03RecarbrioImipenem/Cilastatin/RelebactamDeemed proven: 3 of 3 patient groups
- 2022-05-05FetcrojaCefiderocolDeemed proven
Data status: 2026-10-29